Retinal Diseases
Diseases involving the RETINA.
Subtype terms (23)
More specific conditions that are subtypes of Retinal Diseases in the MeSH hierarchy.
- Angioid Streaks
4 drugs approved
- Central Serous Chorioretinopathy
31 drugs (24 approved, 7 experimental)
- Cone Dystrophy
- Diabetic Retinopathy
165 drugs (74 approved, 91 experimental)
- Epiretinal Membrane
23 drugs (18 approved, 5 experimental)
- Familial Exudative Vitreoretinopathies
1 drug approved
- Foveomacular Retinitis
- Hypertensive Retinopathy
- Leber Congenital Amaurosis
15 drugs (6 approved, 9 experimental)
- Retinal Artery Occlusion
9 drugs (7 approved, 2 experimental)
- Retinal Degeneration
31 drugs (9 approved, 22 experimental)
- Retinal Detachment
39 drugs (32 approved, 7 experimental)
- Retinal Dysplasia
- Retinal Hemorrhage
3 drugs approved
- Retinal Neoplasms
8 drugs approved
- Retinal Neovascularization
7 drugs (3 approved, 4 experimental)
- Retinal Perforations
18 drugs (11 approved, 7 experimental)
- Retinal Telangiectasis
6 drugs (4 approved, 2 experimental)
- Retinal Vasculitis
4 drugs approved
- Retinal Vein Occlusion
46 drugs (30 approved, 16 experimental)
- Retinitis
5 drugs (2 approved, 3 experimental)
- Retinopathy of Prematurity
47 drugs (29 approved, 18 experimental)
- Vitreoretinopathy, Proliferative
29 drugs (25 approved, 4 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (24)
Phase 3 trials (24)
Phase 2 trials (33)
Phase 1 trials (16)
Organizations
Organization Involved with Phase 4 Indications (48)
- Regeneron
- Theratechnologies
- Pfizer
- Sanofi
- Novartis
- Allergan
- Hanlim Pharm. Co., Ltd.
- Aarhus University
- Cairo University
- Hanyang University
- Instituto de Olhos de Goiania
- King Khaled Eye Specialist Hospital
- Nanjing Medical University
- Nihon University
- University of Dundee
- University of Edinburgh
- University of Glasgow
- University of Padova
- University of Rochester
- University of South Alabama
- University of Sydney
- University of Aberdeen
- University of Catania
- University of Cologne
- University of Vienna
- University of Tabriz
- Southeast University
- Taipei Veteran General hospital
- Jiao Tong University
- Beni Suef University
- +18 more
Organization Involved with Phase 3 Indications (90)
- Abbott
- Takeda
- Roche
- Kowa
- AstraZeneca
- Genentech
- Alcon
- Bayer
- BCN Peptides
- Chromaderm, Inc.
- Hannover Clinical Trial Center GmbH
- ProQR Therapeutics
- Tasly Pharmaceuticals, Inc.
- Vitreoretinal Technologies, Inc.
- National Institutes of Health (NIH)
- National Eye Institute (NEI)
- National Heart, Lung, and Blood Institute (NHLBI)
- Queen Silvia Children's Hospital, Gothenburg, Sweden
- Shahid Beheshti University of Medical Sciences
- Huazhong University of Science and Technology
- University of Pennsylvania
- Brown University
- Case Western Reserve University
- Centre Hospitalier Intercommunal Creteil
- Duke University
- Emory University
- Greater Houston Retina Research
- Indiana University
- Instituto Mexicano del Seguro Social
- Joslin Diabetes Center
- +60 more
Organization Involved with Phase 2 Indications (75)
- Acucela Inc.
- Shire
- ISTA Pharmaceuticals
- Bausch & Lomb
- Adverum Biotechnologies, Inc.
- Allegro Ophthalmics, LLC
- Aerpio Therapeutics
- OcuCure Therapeutics, Inc.
- Regenxbio Inc.
- Semler Research Center Pvt. Ltd.
- Tyrogenex
- Boehringer Ingelheim
- The EMMES Corporation
- Vision Research Foundation
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Universidad Nacional Autonoma de Mexico
- Jumper, J. Michael, M.D.
- Ajou University
- Elman Retina Group
- Ferris State University
- Guangdong Women and Children Hospital
- Hospital Juarez de Mexico
- Kyushu University
- Ophthalmic Consultants of Boston
- Ophthalmological Association Edelweiss
- Paracelsus Medical University
- Retina Macula Institute
- Schepens Eye Research Institute
- Rocky Mountain Retina Consultants
- Semmelweis University
- +45 more
Organization Involved with Phase 1 Indications (42)
- Santen Inc.
- GlaxoSmithKline
- MediBeacon
- Opthea Pty Ltd.
- PanOptica, Inc.
- Baylor University
- China Academy of Chinese Medical Sciences
- Manhattan Eye, Ear & Throat Hospital
- Northwestern University
- Retinal Consultants of Arizona
- Rutgers University
- The New York Eye & Ear Infirmary
- The New York Eye Cancer Center
- Texas Retina Associates
- Triemli Hospital
- Smith-Kettlewell Eye Research Institute
- Zhengzhou University
- University of California, Davis
- Vanderbilt University
- Icahn School of Medicine at Mount Sinai
- Anhui College of Traditional Chinese Medicine
- University of Minnesota
- King Faisal Specialist Hospital
- Iran University of Medical Sciences
- American University of Beirut
- Tianjin Medical University
- Isfahan University
- Pomeranian Medical University
- Bangladesh Eye Hospital
- Sun Yat-Sen University
- +12 more
Organization Involved with Other Experimental Indications (28)
- PolyPhotonix Medical
- Fondazione G.B. Bietti, IRCCS
- Narayana Nethralaya
- Dr. Sami Ulus Children's Hospital
- University of London
- Eye Clinic Medic Zuljan Jukic
- Georgetown University
- Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes
- Johns Hopkins University
- Kresge Eye Institute
- McMaster University
- Norwegian University of Science and Technology
- Panhandle Eye Group, LLP
- University of Pavia
- University of Southern California
- University of Bern
- University of Zagreb
- Yonsei University
- Kantonsspital Aarau
- University of British Columbia
- University of Indonesia
- Vita-Salute University of Milano. Italy
- University of Split
- University of Brescia
- University of Western Ontario
- Shanghai Municipal Science and Technology Commission
- Velux Fonden
- Foundation IRCCS San Matteo Hospital